Medications for Familial Homozygous Hypercholesterolemia

5 results
  • juxtapid - lomitapide mesylate capsule

    (Lomitapide Mesylate)
    Amryt Pharmaceuticals Dac
    Juxtapid is used alongside a low-fat diet and other lipid-lowering treatments to reduce LDL cholesterol, total cholesterol, apolipoprotein B, and non-HDL cholesterol in adults with homozygous familial hypercholesterolemia (HoFH).
  • leqvio - inclisiran injection, solution

    (Inclisiran)
    Novartis Pharmaceuticals Corporation
    Leqvio is used with diet and exercise to lower LDL cholesterol in adults with hypercholesterolemia, and in adults and patients aged 12 and older with heterozygous or homozygous familial hypercholesterolemia.
  • lipitor - atorvastatin calcium tablet, film coated

    (Atorvastatin Calcium)
    Viatris Specialty Llc
    Lipitor reduces LDL cholesterol in adults and children 10+ with hyperlipidemia or familial hypercholesterolemia. It also lowers the risk of heart attack, stroke, and cardiovascular procedures in adults with coronary heart disease risk factors, type 2 diabetes, or established heart disease.
  • praluent - alirocumab injection, solution

    (Alirocumab)
    Regeneron Pharmaceuticals, Inc.
    Praluent reduces LDL cholesterol in adults with hypercholesterolemia, HeFH, or HoFH (ages 8+), and lowers the risk of major cardiovascular events—heart attack, stroke, coronary death, or unstable angina—in high-risk adults.
  • repatha - evolocumab injection, solution

    (Evolocumab)
    Amgen Usa Inc.
    Repatha reduces the risk of major cardiovascular events (CV death, heart attack, stroke) in high-risk adults, and lowers LDL cholesterol in adults with hypercholesterolemia and patients aged 10+ with heterozygous or homozygous familial hypercholesterolemia, as an adjunct to diet and exercise.